BETH CARNEY: Open Payments
NPI 1811973118 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 19 payments from 9 companies in 2025. Trend: 2023 $327 · 2024 $418 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $89 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $47 |
| Sage Therapeutics, LLC | 2 | $47 |
| Astellas Pharma US Inc | 2 | $44 |
| MILLICENT US INC | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $19 |
| CooperSurgical, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
Products named: MYFEMBREE, ZURZUVAE, Veozah, INTRAROSA, Qelbree, Phexxi, Paragard T 380A, LILETTA.
Industry payments across PA — which companies pay providers there.
